Cancer as a metabolic disease

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Seyfried, Thomas N ^a   Shelton, Laura M ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTAMINE;

AEROBIC METABOLISM; CANCER CELL; CANCER INVASION; CELL ENERGY; CELL FUNCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; GENOMIC INSTABILITY; GLYCOLYSIS; HUMAN; METABOLIC DISORDER; METASTASIS; NEOPLASM; PHOSPHORYLATION; REVIEW;

EID: 77649277719     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-7     Document Type: Review

References (311)

1. Cancer is a preventable disease that requires major lifestyle changes. P Anand AB Kunnumakkara C Sundaram KB Harikumar ST Tharakan OS Lai B Sung BB Aggarwal, Pharm Res 2008 25 2097 2116 10.1007/s11095-008-9661-9 18626751
2. Cancer undefeated. JC Bailar HL Gornik, N Engl J Med 1997 336 1569 1574 10.1056/NEJM199705293362206 9164814
3. Theories of carcinogenesis: an emerging perspective. C Sonnenschein AM Soto, Semin Cancer Biol 2008 18 372 377 10.1016/j.semcancer.2008.03.012 18472276
4. Paradoxes in carcinogenesis: new opportunities for research directions. SG Baker BS Kramer, BMC Cancer 2007 7 151 10.1186/1471-2407-7-151 17683619
5. The somatic mutation theory of cancer: growing problems with the paradigm? AM Soto C Sonnenschein, Bioessays 2004 26 1097 1107 10.1002/bies.20087 15382143
6. The hallmarks of cancer. D Hanahan RA Weinberg, Cell 2000 100 57 70 10.1016/S0092-8674(00)81683-9 10647931
7. A mutator phenotype in cancer. LA Loeb, Cancer Res 2001 61 3230 3239 11309271
8. The living state and cancer. A Szent-Gyorgyi, Proc Natl Acad Sci USA 1977 74 2844 2847 10.1073/pnas.74.7.2844 268635
9. New guardians of the genome. DB Roth M Gellert, Nature 2000 404 823 825 10.1038/35009180 10786775
10. Targeting energy metabolism in brain cancer: review and hypothesis. TN Seyfried P Mukherjee, Nutr Metab (Lond) 2005 2 30 10.1186/1743-7075-2-30 16242042
11. 'The metabolism of tumours': 70 years later. GL Semenza D Artemov A Bedi Z Bhujwalla K Chiles D Feldser E Laughner R Ravi J Simons P Taghavi H Zhong, Novartis Found Symp 2001 240 251 260 discussion 260-254 full-text 11727934
12. Oxidative metabolism in cancer growth. M Ristow, Curr Opin Clin Nutr Metab Care 2006 9 339 345 10.1097/01.mco.0000232892.43921.98 16778561
13. Why do cancers have high aerobic glycolysis? RA Gatenby RJ Gillies, Nat Rev Cancer 2004 4 891 899 10.1038/nrc1478 15516961
14. Mitochondria in cancer cells: what is so special about them? V Gogvadze S Orrenius B Zhivotovsky, Trends Cell Biol 2008 18 165 173 10.1016/j.tcb.2008.01. 006 18296052
15. Genetic instabilities in human cancers. C Lengauer KW Kinzler B Vogelstein, Nature 1998 396 643 649 10.1038/25292 9872311
16. A range of cancers is associated with the rs6983267 marker on chromosome 8. D Wokolorczyk B Gliniewicz A Sikorski E Zlowocka B Masojc T Debniak J Matyjasik M Mierzejewski K Medrek D Oszutowska J Suchy J Gronwald U Teodorczyk T Huzarski T Byrski A Jakubowska B Gorski T van de Wetering S Walczak SA Narod J Lubinski C Cybulski, Cancer Res 2008 68 9982 9986 10.1158/0008-5472.CAN-08-1838 19047180
17. Tumor progression: a brief historical perspective. PC Nowell, Semin Cancer Biol 2002 12 261 266 10.1016/S1044-579X(02)00012-3 12147207
18. Mitochondria in cancer: Not just innocent bystanders. C Frezza E Gottlieb, Semin Cancer Biol 2008 19101633
19. Glycolysis in cancer: a potential target for therapy. RA Gatenby RJ Gillies, Int J Biochem Cell Biol 2007 39 1358 1366 10.1016/j.biocel.2007.03.021 17499003
20. Understanding the Warburg effect: the metabolic requirements of cell proliferation. MG Vander Heiden LC Cantley CB Thompson, Science 2009 324 1029 1033 10.1126/science.1160809 19460998
21. Glucose avidity of carcinomas. AD Ortega M Sanchez-Arago D Giner-Sanchez L Sanchez-Cenizo I Willers JM Cuezva, Cancer Lett 2009 276 125 135 10.1016/j.canlet.2008.08.007 18790562
22. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. B Altenberg KO Greulich, Genomics 2004 84 1014 1020 10.1016/j.ygeno.2004.08.010 15533718
23. The Metabolism of Tumours. O Warburg, New York, Richard R Smith, 1931
24. On the origin of cancer cells. O Warburg, Science 1956 123 309 314 10.1126/science.123.3191.309 13298683
25. The prime cause of cancer and prevention - Part 2. O Warburg, Annual meeting of Nobelists at Lindau, Germany 1969 http://www.hopeforcancer.com/ OxyPlus.htm
26. The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells? R Moreno-Sanchez S Rodriguez-Enriquez E Saavedra A Marin-Hernandez JC Gallardo-Perez, Biofactors 2009 35 209 225 10.1002/biof.31 19449450
27. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. S Bonnet SL Archer J Allalunis-Turner A Haromy C Beaulieu R Thompson CT Lee GD Lopaschuk L Puttagunta S Bonnet G Harry K Hashimoto CJ Porter MA Andrade B Thebaud ED Michelakis, Cancer Cell 2007 11 37 51 10.1016/j.ccr.2006.10.020 17222789
28. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. GL Semenza, J Bioenerg Biomembr 2007 39 231 234 10.1007/s10863-007-9081-2 17551816
29. Energy metabolism in tumor cells. R Moreno-Sanchez S Rodriguez-Enriquez A Marin-Hernandez E Saavedra, Febs J 2007 274 1393 1418 10.1111/j.1742-4658.2007. 05686.x 17302740
30. The Glycolysis and Respiration of Tumors. AC Aisenberg, New York, Academic Press 1961
31. Mitochondriotoxic compounds for cancer therapy. VR Fantin P Leder, Oncogene 2006 25 4787 4797 10.1038/sj.onc.1209599 16892091
32. A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis. E Hervouet J Demont P Pecina A Vojtiskova J Houstek H Simonnet C Godinot, Carcinogenesis 2005 26 531 539 10.1093/carcin/bgi001 15604095
33. On respiratory impairment in cancer cells. S Weinhouse, Science 1956 124 267 269 10.1126/science.124.3215.267 13351638
34. The Warburg hypothesis fifty years later. S Weinhouse, Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976 87 115 126 10.1007/BF00284370 136820
35. Otto Warburg: Cell Physiologist, Biochemist, and Eccentric. H Krebs, Oxford, Clarendon 1981
36. Cancer's molecular sweet tooth and the Warburg effect. JW Kim CV Dang, Cancer Res 2006 66 8927 8930 10.1158/0008-5472.CAN-06-1501 16982728
37. Cancer cell metabolism: Warburg and beyond. PP Hsu DM Sabatini, Cell 2008 134 703 707 10.1016/j.cell.2008.08.021 18775299
38. Glucose metabolism and cancer. RJ Shaw, Current opinion in cell biology 2006 18 598 608 10.1016/j.ceb.2006.10.005 17046224
39. Tumor suppressors and cell metabolism: a recipe for cancer growth. RG Jones CB Thompson, Genes Dev 2009 23 537 548 10.1101/gad.1756509 19270154
40. Ketone bodies, potential therapeutic uses. RL Veech B Chance Y Kashiwaya HA Lardy GF Cahill Jr, IUBMB Life 2001 51 241 247 10.1080/152165401753311780 11569918
41. Acidic lipids, H(+)-ATPases, and mechanism of oxidative phosphorylation. N Kocherginsky, Physico-chemical ideas 2009 99 20 41
42. The energetics of ion distribution: the origin of the resting electric potential of cells. RL Veech Y Kashiwaya DN Gates MT King K Clarke, IUBMB Life 2002 54 241 252 10.1080/15216540215678 12587974
43. Cytosolic phosphorylation potential. RL Veech JW Lawson NW Cornell HA Krebs, J Biol Chem 1979 254 6538 6547 36399
44. Energy metabolism in respiration-deficient and wild type Chinese hamster fibroblasts in culture. M Donnelly IE Scheffler, J Cell Physiol 1976 89 39 51 10.1002/jcp.1040890105 8468
45. Deviant energetic metabolism of glycolytic cancer cells. LG Baggetto, Biochimie 1992 74 959 974 10.1016/0300-9084(92)90016-8 1477140
46. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. JM Weinberg MA Venkatachalam NF Roeser I Nissim, Proc Natl Acad Sci USA 2000 97 2826 2831 10.1073/pnas.97.6.2826 10717001
47. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. LJ Reitzer BM Wice D Kennell, J Biol Chem 1979 254 2669 2676 429309
48. Increasing mitochondrial substrate-level phosphorylation can rescue respiratory growth of an ATP synthase-deficient yeast. C Schwimmer L Lefebvre-Legendre M Rak A Devin PP Slonimski JP di Rago M Rigoulet, J Biol Chem 2005 280 30751 30759 10.1074/jbc.M501831200 15975925
49. Is cancer a disease of abnormal cellular metabolism?. New angles on an old idea. RJ DeBerardinis, Genet Med 2008 10 767 777 10.1097/GIM. 0b013e31818b0d9b 18941420
50. Succinyl-CoA synthetase is a phosphate target for the activation of mitochondrial metabolism. D Phillips AM Aponte SA French DJ Chess RS Balaban, Biochemistry 2009 48 7140 7149 10.1021/bi900725c 19527071
51. Mitochondria and cancer: Warburg addressed. DC Wallace, Cold Spring Harb Symp Quant Biol 2005 70 363 374 10.1101/sqb.2005.70.035 16869773
52. Tumor mitochondria and the bioenergetics of cancer cells. PL Pedersen, Prog Exp Tumor Res 1978 22 190 274 149996
53. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. M Wu A Neilson AL Swift R Moran J Tamagnine D Parslow S Armistead K Lemire J Orrell J Teich S Chomicz DA Ferrick, Am J Physiol Cell Physiol 2007 292 125 136 10.1152/ajpcell.00247.2006 16971499
54. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. VR Fantin J St-Pierre P Leder, Cancer Cell 2006 9 425 434 10.1016/j.ccr.2006.04.023 16766262
55. The status of Warburg's theory of glycolysis and respiration in tumors. SP Colowick, Quart Rev Biol 1961 36 273 276 10.1086/403479
56. Cancer metabolism: facts, fantasy, and fiction. XL Zu M Guppy, Biochem Biophys Res Commun 2004 313 459 465 10.1016/j.bbrc.2003.11.136 14697210
57. On respiratory impairment in cancer cells. D Burk AL Schade, Science 1956 124 270 272 13351640
58. Spectroscopic evidence of metabolic control. B Chance B Hess, Science 1959 129 700 708 10.1126/science.129.3350.700 13635004
59. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. I Samudio M Fiegl M Andreeff, Cancer Res 2009 69 2163 2166 10.1158/0008-5472.CAN-08-3722 19258498
60. Oxygen consumption can regulate the growth of tumors, a new perspective on the warburg effect. Y Chen R Cairns I Papandreou A Koong NC Denko, PLoS One 2009 4 7033 10.1371/journal.pone.0007033 19753307
61. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. A Ramanathan C Wang SL Schreiber, Proc Natl Acad Sci USA 2005 102 5992 5997 10.1073/pnas.0502267102 15840712
62. Mitochondrial function and energy metabolism in cancer cells: Past overview and future perspectives. A Mayevsky, Mitochondrion 2009 19460294
63. Comparative studies of the heat production of different rat hepatoma cells in culture. R van Wijk J Souren DH Schamhart JC van Miltenburg, Cancer Res 1984 44 671 673 6692371
64. A unifying concept of carcinogenesis and its therapeutic implications. AE Smith DH Kenyon, Oncology 1973 27 459 479 10.1159/000224754 4578174
65. Finding an "Achilles' heel" of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells. M Yuneva, Cell Cycle 2008 7 2083 2089 18635953
66. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. RJ Deberardinis T Cheng, Oncogene 2009 19881548
67. Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling. C Yang J Sudderth T Dang RG Bachoo JG McDonald RJ Deberardinis, Cancer Res 2009
68. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer. AP John, Med Hypotheses 2001 57 429 431 10.1054/mehy.2001.1335 11601863
69. Mitochondrial gateways to cancer. L Galluzzi E Morselli O Kepp I Vitale A Rigoni E Vacchelli M Michaud H Zischka M Castedo G Kroemer, Mol Aspects Med 2009 19698742
70. The mode of mitochondrial degeneration in gliomas. CS Foster PE Spoerri P Glees O Spoerri, Acta Neurochir (Wien) 1978 43 229 237 10.1007/BF01587958 707179
71. Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. AK Rasmussen A Chatterjee LJ Rasmussen KK Singh, Nucleic Acids Res 2003 31 3909 3917 10.1093/nar/gkg446 12853606
72. The bioenergetic signature of cancer: a marker of tumor progression. JM Cuezva M Krajewska ML de Heredia S Krajewski G Santamaria H Kim JM Zapata H Marusawa M Chamorro JC Reed, Cancer Res 2002 62 6674 6681 12438266
73. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: Lipidomic evidence supporting the Warburg theory of cancer. MA Kiebish X Han H Cheng JH Chuang TN Seyfried, J Lipid Res 2008 18703489
74. Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies. GJ Arismendi-Morillo AV Castellano-Ramirez, J Electron Microsc (Tokyo) 2008 57 33 39 10.1093/jmicro/dfm038 18230641
75. In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours. MA Kiebish X Han H Cheng TN Seyfried, ASN Neuro 2009 1
76. Tumor cell energy metabolism and its common features with yeast metabolism. R Diaz-Ruiz S Uribe-Carvajal A Devin M Rigoulet, Biochim Biophys Acta 2009 1796 252 265 19682552
77. Observations on the carbohydrate metabolism of tumors. HG Crabtree, Biochem J 1929 23 536 545 16744238
78. Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. N Bellance G Benard F Furt H Begueret K Smolkova E Passerieux JP Delage JM Baste P Moreau R Rossignol, Int J Biochem Cell Biol 2009 41 2566 2577 10.1016/j.biocel.2009.08.012 19712747
79. Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. F Jiang MT Ryan M Schlame M Zhao Z Gu M Klingenberg N Pfanner ML Greenberg, J Biol Chem 2000 275 22387 22394 10.1074/jbc.M909868199 10777514
80. Cardiolipin defines the interactome of the major ADP/ATP carrier protein of the mitochondrial inner membrane. SM Claypool Y Oktay P Boontheung JA Loo CM Koehler, J Cell Biol 2008 182 937 950 10.1083/jcb.200801152 18779372
81. Mitochondrial dysfunction of a cultured Chinese hamster ovary cell mutant deficient in cardiolipin. T Ohtsuka M Nishijima K Suzuki Y Akamatsu, J Biol Chem 1993 268 22914 22919 8226801
82. Role of cardiolipin alterations in mitochondrial dysfunction and disease. AJ Chicco GC Sparagna, American journal of physiology Cell physiology 2007 292 33 44 10.1152/ajpcell.00243.2006 16899548
83. Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. ZT Schug E Gottlieb, Biochim Biophys Acta 2009 19450542
84. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. RL Veech, Prostaglandins Leukot Essent Fatty Acids 2004 70 309 319 10.1016/j.plefa.2003.09.007 14769489
85. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? D Trachootham J Alexandre P Huang, Nat Rev Drug Discov 2009 8 579 591 10.1038/nrd2803 19478820
86. Functions and dysfunctions of mitochondrial dynamics. SA Detmer DC Chan, Nat Rev Mol Cell Biol 2007 8 870 879 10.1038/nrm2275 17928812
87. Cancer abolishes the tissue type-specific differences in the phenotype of energetic metabolism. P Acebo D Giner P Calvo A Blanco-Rivero AD Ortega PL Fernandez G Roncador E Fernandez-Malave M Chamorro JM Cuezva, Transl Oncol 2009 2 138 145 19701498
88. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. RD Unwin RA Craven P Harnden S Hanrahan N Totty M Knowles I Eardley PJ Selby RE Banks, Proteomics 2003 3 1620 1632 10.1002/pmic.200300464 12923786
89. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. H Simonnet N Alazard K Pfeiffer C Gallou C Beroud J Demont R Bouvier H Schagger C Godinot, Carcinogenesis 2002 23 759 768 10.1093/carcin/23.5.759 12016148
90. Studies in Cancer. Vii. Enzyme Deficiency in Human and Experimental Cancer. RC Roskelley N Mayer BN Horwitt WT Salter, J Clin Invest 1943 22 743 751 10.1172/JCI101447 16695058
91. How aneuploidy affects metabolic control and causes cancer. D Rasnick PH Duesberg, Biochem J 1999 340 Pt 3 621 630 10.1042/0264-6021:3400621 10359645
92. An integrated genomic analysis of human glioblastoma multiforme. DW Parsons S Jones X Zhang JC Lin RJ Leary P Angenendt P Mankoo H Carter IM Siu GL Gallia A Olivi R McLendon BA Rasheed S Keir T Nikolskaya Y Nikolsky DA Busam H Tekleab LA Diaz Jr
93. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. S Jones X Zhang DW Parsons JC Lin RJ Leary P Angenendt P Mankoo H Carter H Kamiyama A Jimeno SM Hong B Fu MT Lin ES Calhoun M Kamiyama K Walter T Nikolskaya Y Nikolsky J Hartigan DR Smith M Hidalgo SD Leach AP Klein EM Jaffee M Goggins A Maitra C Iacobuzio-Donahue JR Eshleman SE Kern RH Hruban R Karchin N Papadopoulos G Parmigiani B Vogelstein VE Velculescu KW Kinzler, Science 2008 321 1801 1806 10.1126/science.1164368 18772397
94. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. PJ Pollard NC Wortham IP Tomlinson, Ann Med 2003 35 632 639 10.1080/07853890310018458 14708972
95. SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma. HX Hao O Khalimonchuk M Schraders N Dephoure JP Bayley H Kunst P Devilee CW Cremers JD Schiffman BG Bentz SP Gygi DR Winge H Kremer J Rutter, Science 2009 19628817
96. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. BE Baysal RE Ferrell JE Willett-Brozick EC Lawrence D Myssiorek A Bosch A van der Mey PE Taschner WS Rubinstein EN Myers CW Richard CJ Cornelisse P Devilee B Devlin, Science 2000 287 848 851 10.1126/science.287.5454.848 10657297
97. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. NA Alam AJ Rowan NC Wortham PJ Pollard M Mitchell JP Tyrer E Barclay E Calonje S Manek SJ Adams PW Bowers NP Burrows R Charles-Holmes LJ Cook BM Daly GP Ford LC Fuller SE Hadfield-Jones N Hardwick AS Highet M Keefe SP MacDonald-Hull ED Potts M Crone S Wilkinson F Camacho-Martinez S Jablonska R Ratnavel A MacDonald RJ Mann K Grice G Guillet MS Lewis-Jones H McGrath DC Seukeran PJ Morrison S Fleming S Rahman D Kelsell I Leigh S Olpin IP Tomlinson, Hum Mol Genet 2003 12 1241 1252 10.1093/hmg/ddg148 12761039
98. The warburg effect is genetically determined in inherited pheochromocytomas. J Favier JJ Briere N Burnichon J Riviere L Vescovo P Benit I Giscos-Douriez A De Reynies J Bertherat C Badoual F Tissier L Amar R Libe PF Plouin X Jeunemaitre P Rustin AP Gimenez-Roqueplo, PLoS One 2009 4 7094 10.1371/journal.pone.0007094 19763184
99. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. D Malkin FP Li LC Strong JF Fraumeni Jr CE Nelson DH Kim J Kassel MA Gryka FZ Bischoff MA Tainsky, et al. Science 1990 250 1233 1238 10.1126/science.1978757 1978757
100. Tumor progression and metastasis. J Yokota, Carcinogenesis 2000 21 497 503 10.1093/carcin/21.3.497 10688870
101. How aneuploidy may cause cancer and genetic instability. P Duesberg D Rasnick R Li L Winters C Rausch R Hehlmann, Anticancer Res 1999 19 4887 4906 10697602
102. Modes of p53 regulation. JP Kruse W Gu, Cell 2009 137 609 622 10.1016/j.cell.2009.04.050 19450511
103. Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. IA Olovnikov JE Kravchenko PM Chumakov, Semin Cancer Biol 2009 19 32 41 10.1016/j.semcancer.2008.11.005 19101635
104. Somatic mutation theory of carcinogenesis: why it should be dropped and replaced. C Sonnenschein AM Soto, Mol Carcinog 2000 29 205 211 10.1002/1098-2744(200012)29:4<205::AID-MC1002>3.0.CO;2-W 11170258
105. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. L Dang DW White S Gross BD Bennett MA Bittinger EM Driggers VR Fantin HG Jang S Jin MC Keenan KM Marks RM Prins PS Ward KE Yen LM Liau JD Rabinowitz LC Cantley CB Thompson MG Vander Heiden SM Su, Nature 2009 19935646
106. Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial dna mutant. A Traven JM Wong D Xu M Sopta CJ Ingles, J Biol Chem 2001 276 4020 4027 10.1074/jbc.M006807200 11054416
107. Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. JR Veatch MA McMurray ZW Nelson DE Gottschling, Cell 2009 137 1247 1258 10.1016/j.cell.2009.04.014 19563757
108. The retrograde response links metabolism with stress responses, chromatin-dependent gene activation, and genome stability in yeast aging. SM Jazwinski, Gene 2005 354 22 27 10.1016/j.gene.2005.03.040 15890475
109. Retrograde regulation due to mitochondrial dysfunction may be an important mechanism for carcinogenesis. A Erol, Med Hypotheses 2005 65 525 529 10.1016/j.mehy.2005.03.022 15905043
110. Mitochondrial signaling: the retrograde response. RA Butow NG Avadhani, Mol Cell 2004 14 1 15 10.1016/S1097-2765(04)00179-0 15068799
111. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. G Amuthan G Biswas HK Ananadatheerthavarada C Vijayasarathy HM Shephard NG Avadhani, Oncogene 2002 21 7839 7849 10.1038/sj.onc.1205983 12420221
112. Common and cell type-specific responses of human cells to mitochondrial dysfunction. MV Miceli SM Jazwinski, Exp Cell Res 2005 302 270 280 10.1016/j.yexcr.2004.09.006 15561107
113. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. KK Singh M Kulawiec I Still MM Desouki J Geradts S Matsui, Gene 2005 354 140 146 10.1016/j.gene.2005.03.027 15979824
114. Mitochondrial retrograde signaling. Z Liu RA Butow, Annu Rev Genet 2006 40 159 185 10.1146/annurev.genet.40.110405.090613 16771627
115. Nuclear gene expression changes due to mitochondrial dysfunction in ARPE-19 cells: implications for age-related macular degeneration. MV Miceli SM Jazwinski, Invest Ophthalmol Vis Sci 2005 46 1765 1773 10.1167/iovs.04-1327 15851580
116. p53 regulates mtDNA copy number and mitocheckpoint pathway. M Kulawiec V Ayyasamy KK Singh, J Carcinog 2009 8 8 10.4103/1477-3163.50893 19439913
117. Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. M Kulawiec A Safina MM Desouki I Still SI Matsui A Bakin KK Singh, Cancer Biol Ther 2008 7
118. Structural and functional consequences of c-N-Ras constitutively associated with intact mitochondria. JC Wolfman SM Planchon J Liao A Wolfman, Biochim Biophys Acta 2006 1763 1108 1124 10.1016/j.bbamcr.2006.07.015 16996152
119. Rtg2 protein links metabolism and genome stability in yeast longevity. C Borghouts A Benguria J Wawryn SM Jazwinski, Genetics 2004 166 765 777 10.1534/genetics.166.2.765 15020466
120. Two mechanisms by which ATP depletion potentiates induction of the mitochondrial permeability transition. G Simbula PA Glascott Jr S Akita JB Hoek JL Farber, Am J Physiol 1997 273 479 488 9277345
121. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. T Arnould S Vankoningsloo P Renard A Houbion N Ninane C Demazy J Remacle M Raes, Embo J 2002 21 53 63 10.1093/emboj/21.1.53 11782425
122. Calcium, calcium-sensing receptor and colon cancer. JF Whitfield, Cancer Lett 2009 275 9 16 10.1016/j.canlet.2008.07.001 18725175
123. Inflammation and cancer. LM Coussens Z Werb, Nature 2002 420 860 867 10.1038/nature01322 12490959
124. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. F Colotta P Allavena A Sica C Garlanda A Mantovani, Carcinogenesis 2009 30 1073 1081 10.1093/carcin/bgp127 19468060
125. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. G Amuthan G Biswas SY Zhang A Klein-Szanto C Vijayasarathy NG Avadhani, Embo J 2001 20 1910 1920 10.1093/emboj/20.8.1910 11296224
126. Mitochondria-to-nucleus stress signaling in mammalian cells: nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis. G Biswas M Guha NG Avadhani, Gene 2005 354 132 139 10.1016/j.gene.2005.03.028 15978749
127. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. GL Semenza, Biochem J 2007 405 1 9 17555402
128. Oncogenic alterations of metabolism. CV Dang GL Semenza, Trends Biochem Sci 1999 24 68 72 10.1016/S0968-0004(98)01344-9 10098401
129. Hypoxia, HIF1 and glucose metabolism in the solid tumour. NC Denko, Nat Rev Cancer 2008 8 705 713 10.1038/nrc2468 19143055
130. Metabolic transformation in cancer. DA Tennant RV Duran H Boulahbel E Gottlieb, Carcinogenesis 2009 30 1269 1280 10.1093/carcin/bgp070 19321800
131. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. A King MA Selak E Gottlieb, Oncogene 2006 25 4675 4682 10.1038/sj.onc.1209594 16892081
132. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. J Rius M Guma C Schachtrup K Akassoglou AS Zinkernagel V Nizet RS Johnson GG Haddad M Karin, Nature 2008 453 807 811 10.1038/nature06905 18432192
133. HIF-1alpha activation by a redox-sensitive pathway mediates cyanide-induced BNIP3 upregulation and mitochondrial-dependent cell death. L Zhang L Li H Liu K Prabhakaran X Zhang JL Borowitz GE Isom, Free Radic Biol Med 2007 43 117 127 10.1016/j.freeradbiomed.2007.04.005 17561100
134. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. HA Haeberle C Durrstein P Rosenberger YM Hosakote J Kuhlicke VA Kempf RP Garofalo HK Eltzschig, PLoS One 2008 3 3352 10.1371/journal.pone.0003352 18839041
135. Hepatitis B virus × protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. EJ Moon CH Jeong JW Jeong KR Kim DY Yu S Murakami CW Kim KW Kim, Faseb J 2004 18 382 384 14688211
136. MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities. CV Dang A Le P Gao, Clin Cancer Res 2009 19861459
137. Maintenance of genome stability in Saccharomyces cerevisiae. RD Kolodner CD Putnam K Myung, Science 2002 297 552 557 10.1126/science.1075277 12142524
138. Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. R Delsite S Kachhap R Anbazhagan E Gabrielson KK Singh, Mol Cancer 2002 1 6 10.1186/1476-4598-1-6 12495447
139. Going APE over ref-1. AR Evans M Limp-Foster MR Kelley, Mutat Res 2000 461 83 108 11018583
140. Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Y Ma RK Bai R Trieu LJ Wong, Biochim Biophys Acta 2010 1797 29 37 10.1016/j.bbabio.2009.07.008 19647716
141. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. MA Lebedeva JS Eaton GS Shadel, Biochim Biophys Acta 2009 1787 328 334 10.1016/j.bbabio.2009.01.004 19413947
142. Watching the watcher: regulation of p53 by mitochondria. AK Holley DK St Clair, Future Oncol 2009 5 117 130 10.2217/14796694.5.1.117 19243304
143. Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway. CS Busso T Iwakuma T Izumi, Oncogene 2009 28 1616 1625 10.1038/onc.2009.5 19219073
144. The cell cycle is a redox cycle: Linking phase-specific targets to cell fate. WC Burhans NH Heintz, Free Radic Biol Med 2009 19486941
145. Calcium microdomains and cell cycle control. M Whitaker, Cell Calcium 2006 40 585 592 10.1016/j.ceca.2006.08.018 17045645
146. CAML loss causes anaphase failure and chromosome missegregation. Y Liu L Malureanu KB Jeganathan DD Tran LD Lindquist JM van Deursen RJ Bram, Cell Cycle 2009 8 940 949 19229138
147. Cell biology. Do centrosome abnormalities lead to cancer? J Marx, Science 2001 292 426 429 10.1126/science.292.5516.426 11330289
148. A localized elevation of cytosolic free calcium is associated with cytokinesis in the zebrafish embryo. DC Chang C Meng, J Cell Biol 1995 131 1539 1545 10.1083/jcb.131.6.1539 8522610
149. Calcium-labile mitotic spindles isolated from sea urchin eggs (Lytechinus variegatus). ED Salmon RR Segall, J Cell Biol 1980 86 355 365 10.1083/jcb.86.2.355 7190569
150. Warburg's cancer theory revisited: a fundamentally new approach. LJ Anghileri, Arch Geschwulstforsch 1983 53 1 8 6860083
151. Cancer morphogenesis: role of mitochondrial failure. E Fosslien, Ann Clin Lab Sci 2008 38 307 329 18988924
152. The global health burden of infection-associated cancers in the year 2002. DM Parkin, Int J Cancer 2006 118 3030 3044 10.1002/ijc.21731 16404738
153. Hepatitis B virus X gene is implicated in liver carcinogenesis. K Koike, Cancer Lett 2009 19464104
154. Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. AJ Clippinger MJ Bouchard, J Virol 2008 82 6798 6811 10.1128/JVI.00154-08 18448529
155. Mitochondria as functional targets of proteins coded by human tumor viruses. DM D'Agostino P Bernardi L Chieco-Bianchi V Ciminale, Adv Cancer Res 2005 94 87 142 10.1016/S0065-230X(05)94003-7 16096000
156. Suppression of tumorigenicity in interspecific reconstituted cells and cybrids. M Koura H Isaka MC Yoshida M Tosu T Sekiguchi, Gann 1982 73 574 580 7152196
157. Cytoplasmic suppression of malignancy. BA Israel WI Schaeffer, In Vitro Cell Dev Biol 1987 23 627 632 10.1007/BF02621071 3654482
158. Tumorigenicity and its suppression in cybrids of mouse and Chinese hamster cell lines. AN Howell R Sager, Proc Natl Acad Sci USA 1978 75 2358 2362 10.1073/pnas.75.5.2358 276880
159. mtDNA mutations increase tumorigenicity in prostate cancer. JA Petros AK Baumann E Ruiz-Pesini MB Amin CQ Sun J Hall S Lim MM Issa WD Flanders SH Hosseini FF Marshall DC Wallace, Proc Natl Acad Sci USA 2005 102 719 724 10.1073/pnas.0408894102 15647368
160. Reprogramming of a melanoma genome by nuclear transplantation. K Hochedlinger R Blelloch C Brennan Y Yamada M Kim L Chin R Jaenisch, Genes Dev 2004 18 1875 1885 10.1101/gad.1213504 15289459
161. Mouse embryos cloned from brain tumors. L Li MC Connelly C Wetmore T Curran JI Morgan, Cancer Res 2003 63 2733 2736 12782575
162. Transplantation of pluripotential nuclei from triploid frog tumors. RG McKinnell BA Deggins DD Labat, Science 1969 165 394 396 10.1126/science.165. 3891.394 5815255
163. The analysis of malignancy by cell fusion: the position in 1988. H Harris, Cancer Res 1988 48 3302 3306 3370633
164. Tumor cell metabolism: cancer's Achilles' heel. G Kroemer J Pouyssegur, Cancer Cell 2008 13 472 482 10.1016/j.ccr.2008.05.005 18538731
165. Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression. D Tzachanis VA Boussiotis, Cell Cycle 2009 8 1019 1025 19270514
166. The Society of Cells: Cancer and the Control of Cell Proliferation. C Sonnenschein AM Soto, New York, Springer-Verlag 1999
167. Actuality of Warburg's views in our understanding of renal cancer metabolism. C Godinot E de Laplanche E Hervouet H Simonnet, J Bioenerg Biomembr 2007 39 235 241 10.1007/s10863-007-9088-8 17665292
168. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma. J Marsh P Mukherjee TN Seyfried, Clin Cancer Res 2008 14 7751 7762 10.1158/1078-0432.CCR-08-0213 19047102
169. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. P Gao I Tchernyshyov TC Chang YS Lee K Kita T Ochi KI Zeller AM De Marzo JE Van Eyk JT Mendell CV Dang, Nature 2009 458 762 765 10.1038/nature07823 19219026
170. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. DR Wise RJ DeBerardinis A Mancuso N Sayed XY Zhang HK Pfeiffer I Nissim E Daikhin M Yudkoff SB McMahon CB Thompson, Proc Natl Acad Sci USA 2008 105 18782 18787 10.1073/pnas.0810199105 19033189
171. Genes and pathways downstream of telomerase in melanoma metastasis. S Bagheri M Nosrati S Li S Fong S Torabian J Rangel DH Moore S Federman RR Laposa FL Baehner RW Sagebiel JE Cleaver C Haqq RJ Debs EH Blackburn M Kashani-Sabet, Proc Natl Acad Sci USA 2006 103 11306 11311 10.1073/pnas.0510085103 16847266
172. Telomerase, mitochondria and oxidative stress. G Saretzki, Exp Gerontol 2009 44 485 492 10.1016/j.exger.2009.05.004 19457450
173. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. JH Santos JN Meyer B Van Houten, Hum Mol Genet 2006 15 1757 1768 10.1093/hmg/ddl098 16613901
174. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. S Ahmed JF Passos MJ Birket T Beckmann S Brings H Peters MA Birch-Machin T von Zglinicki G Saretzki, J Cell Sci 2008 121 1046 1053 10.1242/jcs.019372 18334557
175. Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. P Mukherjee LE Abate TN Seyfried, Clin Cancer Res 2004 10 5622 5629 10.1158/1078-0432.CCR-04-0308 15328205
176. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. P Mukherjee MM El-Abbadi JL Kasperzyk MK Ranes TN Seyfried, Br J Cancer 2002 86 1615 1621 10.1038/sj.bjc.6600298 12085212
177. Angiogenesis: a dynamic balance of stimulators and inhibitors. ML Iruela-Arispe HF Dvorak, Thromb Haemost 1997 78 672 677 9198237
178. The role of angiogenesis in tumor growth. J Folkman, Semin Cancer Biol 1992 3 65 71 1378311
179. Incipient angiogenesis. J Folkman, J Natl Cancer Inst 2000 92 94 95 10.1093/jnci/92.2.94 10639502
180. VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. JI Greenberg DA Cheresh, Expert Opin Biol Ther 2009 9 1347 1356 10.1517/14712590903208883 19761418
181. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. KP Claffey LF Brown LF del Aguila K Tognazzi KT Yeo EJ Manseau HF Dvorak, Cancer Res 1996 56 172 181 8548760
182. The biology of VEGF and its receptors. N Ferrara HP Gerber J LeCouter, Nat Med 2003 9 669 676 10.1038/nm0603-669 12778165
183. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. R Bos PJ van Diest JS de Jong P van der Groep P van der Valk E van der Wall, Histopathology 2005 46 31 36 10.1111/j.1365-2559.2005.02045.x 15656883
184. Comparisons of metastases in different organs: biological and clinical implications. D Tarin, Clin Cancer Res 2008 14 1923 1925 10.1158/1078-0432.CCR- 07-5259 18381928
185. Metastatic cancer cell. M Bacac I Stamenkovic, Annu Rev Pathol 2008 3 221 247 10.1146/annurev.pathmechdis.3.121806.151523 18233952
186. Cancer invasion and metastasis: changing views. MJ Duffy PM McGowan WM Gallagher, J Pathol 2008 214 283 293 10.1002/path.2282 18095256
187. Tumor metastasis: mechanistic insights and clinical challenges. PS Steeg, Nat Med 2006 12 895 904 10.1038/nm1469 16892035
188. Dissemination and growth of cancer cells in metastatic sites. AF Chambers AC Groom IC MacDonald, Nat Rev Cancer 2002 2 563 572 10.1038/nrc865 12154349
189. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. IJ Fidler, Nat Rev Cancer 2003 3 453 458 10.1038/nrc1098 12778135
190. Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer. LC Huysentruyt LM Shelton TN Seyfried, Int J Cancer 2010 126 65 72 10.1002/ijc.24649 19536778
191. Modeling metastasis in vivo. C Khanna K Hunter, Carcinogenesis 2005 26 513 523 10.1093/carcin/bgh261 15358632
192. Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program. PS Steeg, Clin Cancer Res 2008 14 3643 3645 10.1158/1078-0432.CCR-08-1135 18559575
193. Cancer-cell fusion with migratory bone-marrow-derived cells as an explanation for metastasis: new therapeutic paradigms. JM Pawelek, Future Oncol 2008 4 449 452 10.2217/14796694.4.4.449 18684055
194. EMT: when epithelial cells decide to become mesenchymal-like cells. R Kalluri, J Clin Invest 2009 119 1417 1419 10.1172/JCI39675 19487817
195. The clonal evolution of tumor cell populations. PC Nowell, Science 1976 194 23 28 10.1126/science.959840 959840
196. A genetic model for colorectal tumorigenesis. ER Fearon B Vogelstein, Cell 1990 61 759 767 10.1016/0092-8674(90)90186-I 2188735
197. The transcriptional network for mesenchymal transformation of brain tumours. MS Carro WK Lim MJ Alvarez RJ Bollo X Zhao EY Snyder EP Sulman SL Anne F Doetsch H Colman A Lasorella K Aldape A Califano A Iavarone, Nature 1999
198. New evidence for tumour embolism as a mode of metastasis. IR Hart, J Pathol 2009 219 275 276 10.1002/path.2616 19768739
199. Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. K Garber, J Natl Cancer Inst 2008 100 232 233 10.1093/jnci/djn032 18270330
200. Cell Fusion as a Hidden Force in Tumor Progression. X Lu Y Kang, Cancer Res 2009
201. Fusion-induced malignancy?. A preliminary study. (a challenge to today's common wisdom). M Munzarova L Lauerova J Kovarik A Rejthar V Brezina R Kellnerova A Kovarik, Neoplasma 1992 39 79 86 1528312
202. Small cell carcinoma of the lung: macrophage-specific antigens suggest hemopoietic stem cell origin. MR Ruff CB Pert, Science 1984 225 1034 1036 10.1126/science.6089338 6089338
203. Cannibalism: a way to feed on metastatic tumors. S Fais, Cancer Lett 2007 258 155 164 10.1016/j.canlet.2007.09.014 17977647
204. Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model. LC Huysentruyt P Mukherjee D Banerjee LM Shelton TN Seyfried, Int J Cancer 2008 123 73 84 10.1002/ijc.23492 18398829
205. Is cancer a macrophage-mediated autoaggressive disease? M Munzarova J Kovarik, Lancet 1987 1 952 954 10.1016/S0140-6736(87)90295-9 2882343
206. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. JM Pawelek AK Chakraborty, Nat Rev Cancer 2008 8 377 386 10.1038/nrc2371 18385683
207. Tumour-cell fusion as a source of myeloid traits in cancer. JM Pawelek, Lancet Oncol 2005 6 988 993 10.1016/S1470-2045(05)70466-6 16321767
208. The metastatic niche: adapting the foreign soil. B Psaila D Lyden, Nat Rev Cancer 2009 9 285 293 10.1038/nrc2621 19308068
209. Are advanced malignant melanoma cells hybrids between melanocytes and macrophages? M Munzarova L Lauerova J Capkova, Melanoma Res 1992 2 127 129 1643432
210. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. L Lugini P Matarrese A Tinari F Lozupone C Federici E Iessi M Gentile F Luciani G Parmiani L Rivoltini W Malorni S Fais, Cancer Res 2006 66 3629 3638 10.1158/0008-5472.CAN-05-3204 16585188
211. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. H Willenbring AS Bailey M Foster Y Akkari C Dorrell S Olson M Finegold WH Fleming M Grompe, Nat Med 2004 10 744 748 10.1038/nm1062 15195088
212. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. GV Glinsky O Berezovska AB Glinskii, J Clin Invest 2005 115 1503 1521 10.1172/JCI23412 15931389
213. Microenvironmental regulation of metastasis. JA Joyce JW Pollard, Nat Rev Cancer 2009 9 239 252 10.1038/nrc2618 19279573
214. Development and distribution of mononuclear phagocytes: Relevance to inflammation. S Gordon, Inflammation: Basic Principles and Clinical Correlates New York: Lippincott Williams & Wilkins, Snyderman JIGaR, 1999 35 48
215. Distinct role of macrophages in different tumor microenvironments. CE Lewis JW Pollard, Cancer Res 2006 66 605 612 10.1158/0008-5472.CAN-05-4005 16423985
216. Macrophages define the invasive microenvironment in breast cancer. JW Pollard, J Leukoc Biol 2008 84 623 630 10.1189/jlb.1107762 18467655
217. A critical review: The pathology of cerebral gliomas. HJ Scherer, J Neurol Neuropsychiat 1940 3 147 177 10.1136/jnnp.3.2.147
218. Human malignant astrocytes express macrophage phenotype. S Leenstra PK Das D Troost OJ de Boer DA Bosch, J Neuroimmunol 1995 56 17 25 10.1016/0165-5728(94)00128-B 7822478
219. Tumor cell phagocytosis. Its occurrence in a patient with medulloblastoma. E Youness B Barlogie M Ahearn JM Trujillo, Arch Pathol Lab Med 1980 104 651 653 6893661
220. Cytologic findings of medulloblastoma in crush smears. PV Kumar M Hosseinzadeh GR Bedayat, Acta Cytol 2001 45 542 546 11480716
221. Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. I Shabo H Olsson XF Sun J Svanvik, Int J Cancer 2009 125 1826 1831 10.1002/ijc.24506 19582880
222. Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma. T Handerson R Camp M Harigopal D Rimm J Pawelek, Clin Cancer Res 2005 11 2969 2973 10.1158/1078-0432.CCR-04-2211 15837749
223. Cell cannibalism in ductal carcinoma of breast. WT Abodief P Dey O Al-Hattab, Cytopathology 2006 17 304 305 10.1111/j.1365-2303.2006.00326.x 16961662
224. Erythrophagocytosis by epithelial cells of a breast carcinoma. M Marin-Padilla, Cancer 1977 39 1085 1089 10.1002/1097-0142(197703)39:3<1085:: AID-CNCR2820390312>3.0.CO;2-U 199342
225. Phagocytic tumour cells. JL Spivak, Scand J Haematol 1973 11 253 256 4128872
226. Interferon gamma and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines. MR Ruff WL Farrar CB Pert, Proc Natl Acad Sci USA 1986 83 6613 6617 10.1073/pnas.83.17.6613 3018738
227. Hemophagocytosis by small cell lung carcinoma. Y Molad P Stark M Prokocimer H Joshua J Pinkhas Y Sidi, Am J Hematol 1991 36 154 156 10.1002/ajh.2830360218 1849348
228. Erythrophagocytosis by undifferentiated lung carcinoma cells. B Falini E Bucciarelli F Grignani MF Martelli, Cancer 1980 1140 1145 10.1002/1097- 0142(19800901)46:5<1140::AID-CNCR2820460511>3.0.CO;2-B 7214298
229. Phagocytic tumor cell activity in oat cell carcinoma of the lung. PA DeSimone R East RD Powell Jr, Hum Pathol 1980 11 535 539 6253386
230. The cancer cell - leukocyte fusion theory of metastasis. JM Pawelek AK Chakraborty, Adv Cancer Res 2008 101 397 444 10.1016/S0065-230X(08)00410-7 19055949
231. Melanoma × macrophage hybrids with enhanced metastatic potential. M Rachkovsky S Sodi A Chakraborty Y Avissar J Bolognia JM McNiff J Platt D Bermudes J Pawelek, Clin Exp Metastasis 1998 16 299 312 10.1023/A:1006557228604 9626809
232. Erythrophagocytic tumour cells in melanoma and squamous cell carcinoma of the skin. C Monteagudo E Jorda C Carda C Illueca A Peydro A Llombart-Bosch, Histopathology 1997 31 367 373 10.1046/j.1365-2559.1997.2670867.x 9363453
233. Primary invasive signet-ring cell melanoma. F Breier R Feldmann C Fellenz N Neuhold F Gschnait, J Cutan Pathol 1999 26 533 536 10.1111/j.1600-0560.1999. tb01802.x 10599947
234. Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I). D Lazar S Taban A Dema M Cornianu A Goldis I Ratiu I Sporea, Rom J Morphol Embryol 2009 50 41 50 19221644
235. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. CO Sung JW Seo KM Kim IG Do SW Kim CK Park, Mod Pathol 2008 21 1533 1541 10.1038/modpathol.2008.170 18849918
236. Metastatic colorectal carcinoma: an unusual presentation. A Moonda S Fatteh, J Cutan Pathol 2009 36 64 66 10.1111/j.1600-0560.2008.01007.x 18715256
237. Similarities in function between pancreatic tumor cells and macrophages and their inhibition by murine monoclonal antibodies. HU Schorlemmer K Bosslet HF Kern HH Sedlacek, Behring Inst Mitt 1988 240 264 3408453
238. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. S Khayyata O Basturk NV Adsay, Mod Pathol 2005 18 1504 1511 10.1038/modpathol.3800460 16007065
239. Clinical significance of "cannibalism" in urinary cytology of bladder cancer. S Kojima H Sekine I Fukui H Ohshima, Acta Cytol 1998 42 1365 1369 9850644
240. Giant (bizarre) cell variant of renal carcinoma. R Chetty D Cvijan, Histopathology 1997 30 585 587 10.1046/j.1365-2559.1997.5560789.x 9205865
241. Ovarian undifferentiated carcinoma resembling giant cell carcinoma of the lung. M Yasunaga Y Ohishi I Nishimura S Tamiya A Iwasa E Takagi T Inoue H Yahata H Kobayashi N Wake M Tsuneyoshi, Pathol Int 2008 58 244 248 10.1111/j.1440-1827.2008.02218.x 18324918
242. Phagocytosis of collagen by fibroblasts and invasive cancer cells is mediated by MT1-MMP. H Lee KL Sodek Q Hwang TJ Brown M Ringuette J Sodek, Biochem Soc Trans 2007 35 704 706 10.1042/BST0350704 17635128
243. Hemophagocytosis by rhabdomyosarcoma cells in bone marrow. WC Tsoi CS Feng, Am J Hematol 1997 54 340 342 10.1002/(SICI)1096-8652(199704)54:4<340:: AID-AJH17>3.0.CO;2-F 9092697
244. Rhabdomyosarcoma, presenting as disseminated malignancy from an unknown primary site: a retrospective study of ten pediatric cases. E Etcubanas S Peiper S Stass A Green, Med Pediatr Oncol 1989 17 39 44 10.1002/mpo.2950170108 2913473
245. Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells. TN Seyfried, Perspect Biol Med 2001 44 263 282 10.1353/pbm.2001.0035 11370160
246. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. SY Kim JL Roh NK Yeo JS Kim JH Lee SH Choi SY Nam, Ann Oncol 2007 18 1698 1703 10.1093/annonc/mdm270 17716985
247. The anti-carcinogenic effects of dietary restriction: mechanisms and future directions. SD Hursting FW Kari, Mutat Res 1999 443 235 249 10415442
248. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice. DG Jose RA Good, Cancer Res 1973 33 807 812 4633154
249. Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice. KE Wheatley EA Williams NC Smith A Dillard EY Park NP Nunez SD Hursting MA Lane, Nutr Cancer 2008 60 61 68 10.1080/01635580802393118 18444137
250. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. P Mukherjee AV Sotnikov HJ Mangian JR Zhou WJ Visek SK Clinton, J Natl Cancer Inst 1999 91 512 523 10.1093/jnci/91.6.512 10088621
251. Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction. FW Kari SE Dunn JE French JC Barrett, J Nutr Health Aging 1999 3 92 101 10885804
252. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. JC Mavropoulos WC Buschemeyer AK Tewari D Rokhfeld M Pollak Y Zhao PG Febbo P Cohen D Hwang G Devi W Demark-Wahnefried EC Westman BL Peterson SV Pizzo SJ Freedland, Cancer Prev Res (Phila Pa) 2009 2 557 565 19470786
253. Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice. MJ Bonorden OP Rogozina CM Kluczny ME Grossmann PL Grambsch JP Grande S Perkins A Lokshin MP Cleary, Nutr Cancer 2009 61 265 275 10.1080/01635580802419798 19235043
254. Effect of dietary energy restriction on vascular density during mammary carcinogenesis. HJ Thompson JN McGinley NS Spoelstra W Jiang Z Zhu P Wolfe, Cancer Res 2004 64 5643 5650 10.1158/0008-5472.CAN-04-0787 15313902
255. Caloric restriction and experimental carcinogenesis. D Kritchevsky, Toxicol Sci 1999 52 13 16 10630585
256. Nutrition and cancer. A Tannenbaum, Physiopathology of Cancer NY: Paul B. Hober, Homburger F, 1959 517 562
257. Tumours with PI3K activation are resistant to dietary restriction. NY Kalaany DM Sabatini, Nature 2009 458 725 731 10.1038/nature07782 19279572
258. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. SD Hursting SM Smith LM Lashinger AE Harvey SN Perkins, Carcinogenesis 2010 31 83 89 10.1093/carcin/bgp280 19969554
259. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. H Pelicano RH Xu M Du L Feng R Sasaki JS Carew Y Hu L Ramdas L Hu MJ Keating W Zhang W Plunkett P Huang, J Cell Biol 2006 175 913 923 10.1083/jcb.200512100 17158952
260. Sugar and fat - that's where it's at: metabolic changes in tumors. CD Young SM Anderson, Breast Cancer Res 2008 10 202 10.1186/bcr1852 18304378
261. Mechanisms by which energy restriction inhibits carcinogenesis. HJ Thompson W Jiang Z Zhu, Adv Exp Med Biol 1999 470 77 84 10709676
262. Dietary Energy Restriction in Breast Cancer Prevention. HJ Thompson Z Zhu W Jiang, Journal of mammary gland biology and neoplasia 2003 8 133 142 10.1023/A:1025743607445 14587868
263. Dietary and nutritional modulation of tumor angiogenesis. P Mukherjee J-R Zhau AV Sotnikov SK Clinton, Antiangiogenic Agents in Cancer Therapy Totowa, NJ: Humana Press, Teicher BA, 1999 237 261
264. Identification of the apoptosis activation cascade induced in mammary carcinomas by energy restriction. HJ Thompson Z Zhu W Jiang, Cancer Res 2004 64 1541 1545 10.1158/0008-5472.CAN-03-3108 14973070
265. Effects of dietary energy repletion and IGF-1 infusion on the inhibition of mammary carcinogenesis by dietary energy restriction. Z Zhu W Jiang J McGinley P Wolfe HJ Thompson, Molecular carcinogenesis 2005 42 170 176 10.1002/mc.20071 15599926
266. Influence of age and caloric restriction on liver glycolytic enzyme activities and metabolite concentrations in mice. K Hagopian JJ Ramsey R Weindruch, Exp Gerontol 2003 38 253 266 10.1016/S0531-5565(02)00203-6 12581789
267. Gene expression profile of aging and its retardation by caloric restriction. CK Lee RG Klopp R Weindruch TA Prolla, Science 1999 285 1390 1393 10.1126/science.285.5432.1390 10464095
268. Gene-expression profile of the ageing brain in mice. CK Lee R Weindruch TA Prolla, Nat Genet 2000 25 294 297 10.1038/77046 10888876
269. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. JG Mantis NA Centeno MT Todorova R McGowan TN Seyfried, Nutr Metab (Lond) 2004 1 11 10.1186/1743-7075-1-11 15507133
270. Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans. LB Mahoney CA Denny TN Seyfried, Lipids Health Dis 2006 5 13 10.1186/1476-511X-5-13 16709251
271. Starvation in man. GF Cahill Jr, N Engl J Med 1970 282 668 675 4915800
272. Ketoacids? Good medicine? GF Cahill Jr RL Veech, Trans Am Clin Climatol Assoc 2003 114 149 161 discussion 162-143 12813917
273. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. W Zhou P Mukherjee MA Kiebish WT Markis JG Mantis TN Seyfried, Nutr Metab (Lond) 2007 4 5 10.1186/1743-7075-4-5 17313687
274. 3-Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system. M Fredericks RB Ramsey, J Neurochem 1978 31 1529 1531 10.1111/j.1471-4159.1978.tb06581.x 298319
275. Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. MJ Tisdale RA Brennan, Br J Cancer 1983 47 293 297 6130780
276. Targeting energy metabolism in brain cancer with restricted diets. NT Seyfried M Kiebish P Mukherjee, Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies New York: Springer, Ray S, 2010 341 363
277. Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets. TN Seyfried M Kiebish P Mukherjee J Marsh, Epilepsia 2008 49 Suppl 8 114 116 10.1111/j.1528-1167.2008.01853.x 19049606
278. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. TN Seyfried TM Sanderson MM El-Abbadi R McGowan P Mukherjee, Br J Cancer 2003 89 1375 1382 10.1038/sj.bjc.6601269 14520474
279. Anti-Angiogenic and Pro-Apoptotic Effects of Dietary Restriction in Experimental Brain Cancer: Role of Glucose and Ketone Bodies. TN Seyfried P Mukherjee, Integration/Interaction of Oncologic Growth. Cancer Growth and Progression New York: Kluwer Academic, Meadows GG, 2005 15 259 270 full-text
280. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. LC Nebeling F Miraldi SB Shurin E Lerner, J Am Coll Nutr 1995 14 202 208 7790697
281. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. C Otto U Kaemmerer B Illert B Muehling N Pfetzer R Wittig HU Voelker A Thiede JF Coy, BMC Cancer 2008 8 122 10.1186/1471-2407-8-122 18447912
282. Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? JC Mavropoulos WB Isaacs SV Pizzo SJ Freedland, Urology 2006 68 15 18 10.1016/j.urology.2006.03.073 16844447
283. Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. P Mukherjee TJ Mulrooney J Marsh D Blair TC Chiles TN Seyfried, Mol Cancer 2008 7 37 10.1186/1476-4598-7-37 18474106
284. Cancer cachexia: the molecular mechanisms. JM Argiles R Moore-Carrasco G Fuster S Busquets FJ Lopez-Soriano, Int J Biochem Cell Biol 2003 35 405 409 10.1016/S1357-2725(02)00251-0 12565701
285. Cancer anorexia and cachexia. MJ Tisdale, Nutrition 2001 17 438 442 10.1016/S0899-9007(01)00506-8 11377146
286. Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle. PT Todorov SM Wyke MJ Tisdale, Cancer Res 2007 67 11419 11427 10.1158/0008-5472.CAN-07-2602 18056470
287. Biology of cachexia. MJ Tisdale, J Natl Cancer Inst 1997 89 1763 1773 10.1093/jnci/89.23.1763 9392617
288. The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? M Lopez-Lazaro, Anticancer Agents Med Chem 2008 8 305 312 10.2174/187152008783961932 18393789
289. Targeting of cancer energy metabolism. S Rodriguez-Enriquez A Marin-Hernandez JC Gallardo-Perez L Carreno-Fuentes R Moreno-Sanchez, Mol Nutr Food Res 2009 53 29 48 10.1002/mnfr.200700470 19123180
290. Glycolysis inhibition for anticancer treatment. H Pelicano DS Martin RH Xu P Huang, Oncogene 2006 25 4633 4646 10.1038/sj.onc.1209597 16892078
291. Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet. J Marsh P Mukherjee TN Seyfried, Nutr Metab (Lond) 2008 5 33 10.1186/1743-7075-5-33 19032781
292. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. HF Dvorak, N Engl J Med 1986 315 1650 1659 3537791
293. Altered alveolar macrophage function in calorie-restricted rats. W Dong MK Selgrade IM Gilmour RW Lange P Park MI Luster FW Kari, Am J Respir Cell Mol Biol 1998 19 462 469 9730874
294. Glutamine and cancer. MA Medina, J Nutr 2001 131 2539S 2542S discussion 2550S-2531S 11533309
295. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? P Newsholme, J Nutr 2001 131 2515S 2522S discussion 2523S-2514S 11533304
296. The biochemical basis of metabolism in cancer cachexia. AJ Tijerina, Dimens Crit Care Nurs 2004 23 237 243 10.1097/00003465-200411000-00001 15586034
297. Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine. SC Piscitelli A Thibault WD Figg A Tompkins D Headlee R Lieberman D Samid CE Myers, J Clin Pharmacol 1995 35 368 373 7650225
298. Cancer Facts & Figures 2009. American Cancer Society, American Cancer Society, Atlanta 2009 68
299. Hydroperoxide metabolism in mammalian organs. B Chance H Sies A Boveris, Physiol Rev 1979 59 527 605 37532
300. Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. DR Ziegler LC Ribeiro M Hagenn IR Siqueira E Araujo IL Torres C Gottfried CA Netto CA Goncalves, Neurochem Res 2003 28 1793 1797 10.1023/A:1026107405399 14649719
301. Breast cancer risk after caloric restriction during the 1944-1945 Dutch famine. SG Elias PH Peeters DE Grobbee PA van Noord, J Natl Cancer Inst 2004 96 539 546 15069116
302. Cancer risk from extreme stressors: lessons from European Jewish survivors of World War II. SD Hursting MR Forman, J Natl Cancer Inst 2009 101 1436 1437 10.1093/jnci/djp357 19861304
303. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. YL Qiao SM Dawsey F Kamangar JH Fan CC Abnet XD Sun LL Johnson MH Gail ZW Dong B Yu SD Mark PR Taylor, J Natl Cancer Inst 2009 101 507 518 10.1093/jnci/djp037 19318634
304. A ketogenic diet increases succinic dehydrogenase activity in aging cardiomyocytes. M Balietti P Fattoretti B Giorgetti T Casoli G Di Stefano M Solazzi D Platano G Aicardi C Bertoni-Freddari, Ann N Y Acad Sci 2009 1171 377 384 10.1111/j.1749-6632.2009.04704.x 19723079
305. Insulin, ketone bodies, and mitochondrial energy transduction. K Sato Y Kashiwaya CA Keon N Tsuchiya MT King GK Radda B Chance K Clarke RL Veech, Faseb J 1995 9 651 658 7768357
306. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice. MP Cleary MK Jacobson FC Phillips SC Getzin JP Grande NJ Maihle, Cancer Epidemiol Biomarkers Prev 2002 11 836 843 12223427
307. Fundamentals of nutrition: applications to cancer research. D Kritchevsky, Nutritional Oncology Boston: Academic Press, Heber D, Blackburn GL, Go VLW, 1999 5 10
308. Caloric restriction and experimental mammary carcinogenesis. D Kritchevsky, Breast Cancer Res Treat 1997 46 161 167 10.1023/A:1005960410225 9478271
309. Effect of ultraviolet B radiation on activator protein 1 constituent proteins and modulation by dietary energy restriction in SKH-1 mouse skin. BD Hopper J Przybyszewski HW Chen KD Hammer DF Birt, Mol Carcinog 2009 48 843 852 10.1002/mc.20529 19263438
310. Effect of caloric restriction on colonic proliferation in obese persons: implications for colon cancer prevention. G Steinbach S Heymsfield NE Olansen A Tighe PR Holt, Cancer Res 1994 54 1194 1197 8118805
311. Caloric intake, body weight, and cancer: a review. D Albanes, Nutr Cancer 1987 9 199 217 10.1080/01635588709513929 3299283